Susan Fernandez Chamberlin
Albuquerque,NM
Summary
Results-driven pharmaceutical sales leader with a history of surpassing sales goals across multiple therapeutic areas. A four-time President’s Club Winner, driving market share growth through strong relationships with healthcare providers and collaboration. Focused on enhancing patient health outcomes through strategic initiatives and effective territory management.
Overview
32
32
years of professional experience
Work History
Area Business Director, NM, El Paso, CO
ARDELYX
Albuquerque, New Mexico
09.2023 - Current
- Led business development and Customer engagement across a multistate specialty territory, build relationships with nephrologists, dialysis organizations and cross-functional partners to support patient access and territory growth. Recognized as a top sales producer and goal attainer, earning multiple performance recognition awards, contest wins, and monetary awards. Ranked #5 in prescribers.
- Consistently prioritize the right customers through territory analysis, execute the fundamentals, and make every interaction count.
- Expert in specialty pharmacy processes. Educate customers to navigate company hub and specialty pharmacy requirements to help facilitate patient access.
- Implemented strategic initiatives to enhance operational efficiency. to enhance business operations and drive growth.
- Collaborate with cross-functional teams to align goals and resources effectively.
Executive Renal Hospital Specialist, New Mexico and El Paso, Lokelma and Farxiga
ASTRAZENECA
11.2020 - 10.2023
- Launched Farxiga for CKD with Nephrologists, leader in the region in growth and volume.
- Hired as a Hospital Rep for Lokelma, gaining hospital formulary acceptance, becoming the market leader.
- Tasked to change the trajectory of Lokelma in the retail sector where it was never above 75% to plan in this territory since launch.
- Through customer collaboration, perseverance, and tenacity; “relaunched” Lokelma and finished above the nation at 110%.
- Exceeded Farxiga goal of 187% at Launch, continuing to grow with an 84% NRx market share.
- Grew market share of Lokelma in Hospitals from 7% to 45%, not including a recent win at UMC El Paso.
- Turned around Lokelma, finished 110% to plan, FSIP at 125%, and grew market share from 25% to 35%.
Executive Cardiovascular Sales Specialist, New Mexico
NOVARTIS
01.2015 - 01.2020
- Acted as the primary CV representative to develop market and drive demand for the successful launch of a novel drug.
- Effectively prepared the market and launched the first in Class Heart Failure drug, Entresto.
- Achieved formulary acceptance in unprecedented time, as the average acceptance period is typically 4 years with this IDN.
- Collaborated with key stakeholders across largest IDN in NM to achieve formulary acceptance within 1.5 years of launch at Presbyterian.
- Secured formulary preferred status with no prior authorization across 90% of national and local health care plans through collaboration with key thought leaders and staff.
- Captured 35% market share in the Heart Failure sector through strategic marketing initiatives.
- Achieved recognition as a President’s Club Winner in 2017 for outstanding sales performance.
- Secured 1st place nationally in the Beat the Best Competition in 2017 for top performance.
Senior Biopharmaceutical Representative, Cardiovascular Specialty, NM and El Paso
AMGEN
01.2014 - 01.2015
- Prepared market for launch of Heart Failure drug Corlanor and PCSK9 lipid lowering drug Repatha through disease awareness initiatives and relationship development with healthcare providers.
- Secured ACC accreditation in lipid management and heart failure treatment to enhance professional credibility and expertise.
Executive Professional Representative, Central and Northern NM, Primary and Specialty Care
MERCK & CO., INC.
01.2004 - 01.2014
- Exceeded sales and market share objectives across Diabetes, Cardiovascular, Anti-Inflammatory, Oral Antibiotics, and Respiratory sectors.
- Achieved Region Award for highest share growth in Diabetes franchise.
- Region Rank 1/17 in Lipid franchise, 2014.
- Region overall Rank of 2/130, 2005, and 1/100 2009.
- Ranked top 10% in region sales and market share change in 2004, 2005, 2009.
- Key accomplishments: President’s Club Winner in 2005, 2009.
- Recognized as Most Valuable Peer in 2006 for exceptional collaboration and teamwork.
- Managed territories and accounts to successfully launch products across multiple therapeutic areas.
Executive Professional Hospital representative, Specialty and Primary
MERCK & CO., INC.
01.1995 - 01.2003
- Launched, and consistently maintained or exceeded revenue for Cardiovascular, Diabetes, Anti-Inflammatory, Migraine, Osteoporosis and Prostate products at key teaching Hospitals, Federal Accounts and Independent Medical Groups.
- Secured contracts and executed formulary strategies for primary products, enhancing market access.
- Surpassed sales growth targets, achieving Region rank of 2 out of 144 in 2003.
- Spearheaded regional business planning, resulting in the Region Business Planning Award in 2003.
- Key accomplishments: President’s Club Winner, 1999.
Education
BBA - Marketing
University of New Mexico
AlbuquerqueSkills
- Market analysis and strategic planning
- Account management and solution selling
- Problem solving and effective communication
- Cross-functional collaboration
- Specialty pharmacy processes
Timeline
Area Business Director, NM, El Paso, CO
ARDELYX
09.2023 - Current
Executive Renal Hospital Specialist, New Mexico and El Paso, Lokelma and Farxiga
ASTRAZENECA
11.2020 - 10.2023
Executive Cardiovascular Sales Specialist, New Mexico
NOVARTIS
01.2015 - 01.2020
Senior Biopharmaceutical Representative, Cardiovascular Specialty, NM and El Paso
AMGEN
01.2014 - 01.2015
Executive Professional Representative, Central and Northern NM, Primary and Specialty Care
MERCK & CO., INC.
01.2004 - 01.2014
Executive Professional Hospital representative, Specialty and Primary
MERCK & CO., INC.
01.1995 - 01.2003
BBA - Marketing
University of New Mexico